This recall follows Clinical Specialties’ recall of Avastin due to reports of eye infections associated with the product. While there have been no reports of contamination with sterile products other than specified lots of Avastin, the company is recalling all sterile products due to concerns about practices at the site that may not assure sterility.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The recalled products were distributed between Oct. 19, 2012, and March 19, 2013.
More Articles on Infection Control:
4 Pillars of Establishing Successful Standardized Infection Prevention Programs in ASCs
Med Prep Consulting Recalls All Compounded Products
$743.7M in Infection Prevention Funding Requested by APIC, SHEA
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
